Literature DB >> 12401870

Steroid therapy in chronic interstitial renal fibrosis: the case of Chinese-herb nephropathy.

Marie-Carmen Muniz Martinez, Joëlle Nortier, Pierre Vereerstraeten, Jean-Louis Vanherweghem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12401870     DOI： 10.1093/ndt/17.11.2033-a

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  6 in total

Review 1.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

2.  Preventing aristolochic acid nephropathy.

Authors:  Nelomi Anandagoda; Graham M Lord
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-13       Impact factor: 8.237

Review 3.  Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition.

Authors:  Thomas Baudoux; Inès Jadot; Anne-Emilie Declèves; Marie-Hélène Antoine; Jean-Marie Colet; Olivia Botton; Eric De Prez; Agnieszka Pozdzik; Cécile Husson; Nathalie Caron; Joëlle L Nortier
Journal:  Front Med (Lausanne)       Date:  2022-05-04

4.  Smad7 protects against chronic aristolochic acid nephropathy in mice.

Authors:  Xiao-Yu Dai; Li Zhou; Xiao-Ru Huang; Ping Fu; Hui-Yao Lan
Journal:  Oncotarget       Date:  2015-05-20

5.  Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathology.

Authors:  Linghong Huang; Alessandra Scarpellini; Muriel Funck; Elisabetta A M Verderio; Timothy S Johnson
Journal:  Nephron Extra       Date:  2013-01-11

6.  Update of aristolochic acid nephropathy in Korea.

Authors:  Tae Hyun Ban; Ji-Won Min; Changhwan Seo; Da Rae Kim; Yu Ho Lee; Byung Ha Chung; Kyung-Hwan Jeong; Jae Wook Lee; Beom Seok Kim; Sang-Ho Lee; Bum Soon Choi; Jin Suk Han; Chul Woo Yang
Journal:  Korean J Intern Med       Date:  2018-03-20       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.